- ICH GCP
- Amerikanska kliniska prövningsregistret
- Search trials
Kliniska prövningar sponsrade av Peking University Eye Center
Totalt 750 resultat
-
Peking University Cancer Hospital & InstituteHar inte rekryterat ännuSlemhinnemelanom | Neoadjuvant behandlingKina
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekryteringSlemhinnemelanomKina
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekryteringLaparoskopisk kirurgi | Magcancer | Gastrektomi | LymfadenektomiKina
-
Peking University Cancer Hospital & InstituteAvslutadCancerpatienter | FunktionsförlängningKina
-
Peking University Cancer Hospital & InstituteAvslutad
-
Peking University Cancer Hospital & InstituteAktiv, inte rekryterandeCancerrelaterat problem/tillståndKina
-
Peking University Cancer Hospital & InstituteAvslutadLungcancer MetastaserandeKina
-
Peking University Cancer Hospital & InstituteAvslutad
-
Peking University Cancer Hospital & InstituteAvslutad
-
Peking University Cancer Hospital & InstituteOkändMagnetisk resonanstomografi | PositronemissionstomografiKina
-
Peking University Cancer Hospital & InstituteOkändHepatocellulärt karcinom | Transarteriell kemoembolisering
-
Peking University Cancer Hospital & InstituteOkänd
-
Peking University Cancer Hospital & InstituteOkändGastrointestinal cancer MetastaserandeKina
-
Peking University Cancer Hospital & InstituteOkänd
-
Peking University Cancer Hospital & InstituteAvslutadCancerrelaterat problem/tillstånd
-
Peking University Cancer Hospital & InstituteOkändMagcancer | Gastroesofageal cancer
-
Peking University Cancer Hospital & InstituteOkändNeoplasmer i levernKina
-
Peking University Cancer Hospital & InstituteOkändGastrointestinala neoplasmerKina
-
Peking University Cancer Hospital & InstituteOkänd
-
Peking University Cancer Hospital & InstituteOkändLymfom, stor B-cell, diffusKina
-
Peking University Cancer Hospital & InstituteOkändGastrointestinal stromal tumörKina
-
Peking University Cancer Hospital & InstituteAvslutad
-
Peking University Cancer Hospital & InstituteAvslutadBröstneoplasmer | Neoplasma Metastas | Immunterapi | Profilering av genuttryckKina
-
Peking University Cancer Hospital & InstituteOkändGastrointestinala neoplasmerKina
-
Peking University Cancer Hospital & InstituteAvslutadBröstneoplasmer | Neoplasma MetastasKina
-
Peking University Cancer Hospital & InstituteOkänd
-
Peking University People's HospitalJiangsu Cancer Institute & Hospital; Peking University Health Science Center och andra samarbetspartnersAvslutad
-
Peking University Cancer Hospital & InstituteRekryteringAnti-PD-1/PD-L1 kombinerat med anti-angiogena medel som förstahandsbehandling för icke-operabelt HCCOoperabelt hepatocellulärt karcinomKina
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekryteringOvarial, äggledare och primär peritoneal karcinomKina
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekryteringAvancerad malign neoplasmKina
-
Peking University Cancer Hospital & InstituteHar inte rekryterat ännu
-
Peking University Cancer Hospital & InstituteRekryteringKolorektala levermetastaserKina
-
Peking University Cancer Hospital & InstituteRekryteringAvancerat hepatocellulärt karcinom (HCC)Kina
-
Peking University Cancer Hospital & InstituteRekryteringMagcancer | Gastriskt adenokarcinomKina
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekryteringKoloncancer | Cirkulerande tumör-DNAKina
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteHar inte rekryterat ännuPositronemissionstomografi
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteRekryteringHER2-positiv metastaserad bröstcancer | Tidigare behandlad med Trastuzumab | Trastuzumab kombinerat med pertuzumab och kemoterapiKina
-
Peking University Cancer Hospital & InstituteRekrytering
-
Peking University Cancer Hospital & InstituteHar inte rekryterat ännu